Manchester Royal Infirmary Virtual Biologics Clinic
gastroenterology and dermatology, including at an event for the National IBD audit. Implementing up-to-date high-quality research...
Search results
10 results for ibd
-
-
Colonoscopic surveillance in adults with Ulcerative colitis, Crohn's disease or adenomas - Is this happening?
and over with ulcerative colitis or Crohn's disease (types of inflammatory bowel disease) or adenomas (also known as polyps). It aims to...
-
The New Faecal Calprotectin Care Pathway
guidance DG11, for the detection of inflammation in the bowel (i.e. IBS vs IBD). Uptake of this guidance has previously been poor and...
-
Supporting patients with gastrointestinal problems: better pathway, better outcomes
Victoria Hilton and her team, finalists of the NICE Shared Learning Awards, tell us about an improved care pathway to support better outcomes for patients with gastrointestinal problems
-
New type of treatment for Crohn's disease is approved by NICE
Following NICE recommendations, patients with Crohn’s disease will have routine NHS access to drug ustekinumab, which offers a new way of treating the condition.
-
Implementing faecal calprotectin testing in primary care
option to support clinicians with the differential diagnosis of inflammatory bowel disease (IBD) or irritable bowel...
-
Evaluation of guidelines for the use of faecal calprotectin testing in primary care
cancer is not suspected and it is used to support a diagnosis of inflammatory bowel disease (IBD) or irritable bowel...
-
Therapeutic Review- A NICE way to optimise prescribing
use of: - Biologics in Rheumatoid Arthritis(RA), Psoriasis & Inflammatory Bowel Disease (IBD) using NICE algorithms &...
-
Simple tests could help diagnose serious bowel conditions
A simple stool test could help GPs decide whether patients have irritable bowel syndrome (IBS) or other more serious bowel conditions.
-
Symptom relief key for common 'distressing' bowel condition
Symptom relief through the range of recommended drugs and treatments available should be the primary outcome for patients with ulcerative colitis, according to NICE.